Levin ED, Bradley A, Addy N, Sigurani N (2002) Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory. Neuroscience 109:757–765PubMed

Levin ED, Sledge D, Baruah A, Addy NA (2003) Ventral hippocampal NMDA blockade and nicotinic effects on memory function. Brain Res Bull 61:489–495PubMed

Levin E, Icenogle L, Farzad A (2005a) Ketanserin attenuates nicotine-induced working memory improvement in rats. Pharmacol Biochem Behav 82:289–292

Levin ED, Tizabi Y, Rezvani AH, Caldwell DP, Petro A, Getachew B (2005b) Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding. Brain Res 1041:132–142

Li XM, Li CC, Yu SS, Chen JT, Sabapathy K, Ruan DY (2007) JNK1 contributes to metabotropic glutamate receptor-dependent long-term depression and short-term synaptic plasticity in the mice area hippocampal CA1. Eur J Neurosci 25:391–396PubMed

Lotfipour S, Byun JS, Leach P et al (2013) Targeted deletion of the mouse alpha2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors. J Neurosci 33:7728–7741PubMed

Lynch G, Kessler M, Arai A, Larson J (1990) The nature and causes of hippocampal long-term potentiation. Prog Brain Res 83:233–250PubMed

Marks MJ (1999) Desensitization and the regulation of neuronal nicotinic receptors. In: Arneric SP, Brioni JD (eds) Neuronal nicotinic receptors: pharmacology and therapeutic opportunities. Wiley-Liss, New York, pp 65–80

Marks MJ, Collins AC (1982) Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. Mol Pharmacol 22:554–564PubMed

Marks MJ, Burch JB, Collins AC (1983) Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther 226:817–825PubMed

Marks MJ, Stitzel JA, Collins AC (1985) Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther 235:619–628PubMed

Marks MJ, Stitzel JA, Romm E, Wehner JM, Collins AC (1986) Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin. Mol Pharmacol 30:427–436PubMed

Marks MJ, Grady SR, Collins AC (1993) Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther 266:1268–1276PubMed

Matsuyama S, Matsumoto A (2003) Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP. J Pharmacol Sci. 93:180–187PubMed

Matsuyama S, Matsumoto A, Enomoto T, Nishizaki T (2000) Activation of nicotinic acetylcholine receptors induces long-term potentiation in vivo in the intact mouse dentate gyrus. Eur J Neurosci 12:3741–3747PubMed

Matta SG, Balfour DJ, Benowitz NL et al (2007) Guidelines on nicotine dose selection for in vivo research. Psychopharmacology 190:269–319PubMed

McCallum SE, Caggiula AR, Booth S, Breese CR, Lee MJ, Donny EC, Sved AF (2000) Mecamylamine prevents tolerance but enhances whole brain [3H] epibatidine binding in response to repeated nicotine administration in rats. Psychopharmacology 150:1–8PubMed

McEchron MD, Bouwmeester H, Tseng W, Weiss C, Disterhoft JF (1998) Hippocampectomy disrupts auditory trace fear conditioning and contextual fear conditioning in the rat. Hippocampus 8:638–646PubMed

McGehee DS (1999) Molecular diversity of neuronal nicotinic acetylcholine receptors. Ann N Y Acad Sci 868:565–577PubMed

McKay BE, Placzek AN, & Dani JA (2007) Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors. Biochem Pharmacol, 74:1120–1133

Mendrek A, Monterosso J, Simon SL, Jarvik M, Brody A, Olmstead R, Domier CP, Cohen MS, Ernst M, London ED (2006) Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence. Addict Behav 31:833–844PubMedCentralPubMed

Morris RG, Anderson E, Lynch GS, Baudry M (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319:774–776PubMed

Myers CS, Taylor RC, Moolchan ET, Heishman SJ (2008) Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray. Neuropsychopharmacology 33:588–598PubMed

Nakazawa K, Quirk MC, Chitwood RA, Watanabe M, Yeckel MF, Sun LD et al (2002) Requirement for hippocampal CA3 NMDA receptors in associative memory recall. Science 297:211–218PubMedCentralPubMed

Nguyen PV, Abel T, Kandel ER (1994) Requirement of a critical period of transcription for induction of a late phase of LTP. Science 265:1104–1107PubMed

Nicoll RA, Malenka RC (1999) Expression mechanisms underlying NMDA receptor-dependent long-term potentiation. Ann N Y Acad Sci 868:515–525

O’Dell LE, Bruijnzeel AW, Smith RT, Parsons LH, Merves ML, Goldberger BA, Richardson HN, Koob GF, Markou A (2006) Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction. Psychopharmacology 186:612–619PubMed

Olale F, Gerzanich V, Kuryatov A, Wang F, Lindstrom J (1997) Chronic nicotine exposure differentially affects the function of human alpha3, alpha4, and alpha7 neuronal nicotinic receptor subtypes. J Pharmacol Exp Ther 283:675–683PubMed

Orr-Urtreger A, Seldin MF, Baldini A, Beaudet AL (1995) Cloning and mapping of the mouse alpha 7-neuronal nicotinic acetylcholine receptor. Genomics 26:399–402PubMed

Orr-Urtreger A, Goldner FM, Saeki M et al (1997) Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci 17:9165–9171PubMed

Otani S, Marshall CJ, Tate WP, Goddard GV, Abraham WC (1989) Maintenance of long-term potentiation in rat dentate gyrus requires protein synthesis but not messenger RNA synthesis immediately post-tetanization. Neuroscience 28:519–526PubMed

Park S, Knopick C, McGurk S, Meltzer HY (2000) Nicotine impairs spatial working memory while leaving spatial attention intact. Neuropsychopharmacology 22:200–209PubMed